t-Plasminogen Activator/tPA Antibodies
We offer t-Plasminogen Activator/tPA Antibodies for use in common research applications: ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry-Paraffin, Western Blot. Each t-Plasminogen Activator/tPA Antibody is fully covered by our Guarantee+, to give you complete peace of mind and the support when you need it. Our t-Plasminogen Activator/tPA Antibodies can be used in a variety of model species: Human, Mouse, Rat. Use the list below to choose the t-Plasminogen Activator/tPA Antibody which is most appropriate for your research; you can click on each one to view full technical details, images, references, reviews and related products. Choose from our t-Plasminogen Activator/tPA polyclonal antibodies and browse our t-Plasminogen Activator/tPA monoclonal antibody catalog.
Alternate Names for t-Plasminogen Activator/tPA Antibodies
anti-t-Plasminogen Activator/tPA antibody, anti-PLAT antibody, anti-Alteplase antibody, anti-DKFZp686I03148 antibody, anti-EC 3.4.21 antibody, anti-EC 3.4.21.68 antibody, anti-plasminogen activator, tissue antibody, anti-plasminogen activator, tissue type antibody, anti-reteplase antibody, anti-T-PA antibody, anti-t-plasminogen activator antibody, anti-tissue plasminogen activator (t-PA) antibody, anti-tissue-type plasminogen activator antibody, anti-tPA antibody
11 Results for "t-plasminogen-activator-tpa" in Primary Antibodies
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - A. 30 ug PC-12 whole cell lysate/extract 7.5% SDS-PAGE tPA antibody dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Western-Blot-NBP2-20648-img0019.jpg "Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - A. 30 ug PC-12 whole cell lysate/extract 7.5% SDS-PAGE tPA antibody dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.")
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Colon carcinoma. tPA antibody dilution: 1:250. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP2-20648-img0021.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Human plasma (30 ug) was separated by 7.5% SDS-PAGE, and the membrane was blotted with tPA antibody diluted at 1:2000.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Western-Blot-NBP2-20648-img0016.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Sample (30 ug of whole cell lysate) A: 293T 7. 5% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Western-Blot-NBP2-20648-img0017.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - A. 30 ug Neuro2A whole cell lysate/extract 7.5% SDS-PAGE tPA antibody dilution: 1:1000 The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Western-Blot-NBP2-20648-img0018.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Human hepatoma. tPA antibody dilution: 1:500. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP2-20648-img0020.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody [NBP2-20648] - Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with t-Plasminogen Activator/tPA antibody (NBP2-20648) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20648_rabbit-polyclonal-t-plasminogen-activator-tpa-antibody-91020242011476.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of HEK293T cells were transiently transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY t-Plasminogen.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Western-Blot-NBP2-46435-img0007.jpg "Western Blot: t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of HEK293T cells were transiently transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY t-Plasminogen.")
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody (OTI3H3) [NBP2-46435] - t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Immunohistochemistry-NBP2-46435-img0006.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody (OTI3H3) [NBP2-46435] - t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Immunohistochemistry-NBP2-46435-img0001.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody (OTI3H3) [NBP2-46435] - t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Immunohistochemistry-NBP2-46435-img0002.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody (OTI3H3) [NBP2-46435] - t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Immunohistochemistry-NBP2-46435-img0003.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody (OTI3H3) [NBP2-46435] - t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Immunohistochemistry-NBP2-46435-img0004.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody (OTI3H3) [NBP2-46435] - t-Plasminogen Activator/tPA Antibody (3H3) [NBP2-46435] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-3H3-Immunohistochemistry-NBP2-46435-img0005.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of HEK293T cells were transiently transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY t-Plasminogen.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Western-Blot-NBP2-74568-img0001.jpg "Western Blot: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of HEK293T cells were transiently transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY t-Plasminogen.")
![Immunohistochemistry: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74568-img0006.jpg)
![Immunohistochemistry: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74568-img0002.jpg)
![Immunohistochemistry: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74568-img0003.jpg)
![Immunohistochemistry: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74568-img0004.jpg)
![Immunohistochemistry: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74568-img0005.jpg)
![Immunohistochemistry: t-Plasminogen Activator/tPA Antibody (OTI3H3) - Azide and BSA Free [NBP2-74568] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-OTI3H3-Azide-and-BSA-Free-Immunohistochemistry-NBP2-74568-img0007.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP1-87491] - Staining of human Skin shows no cytoplasmic positivity in epidermal cells as expected.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP1-87491-img0011.jpg "Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP1-87491] - Staining of human Skin shows no cytoplasmic positivity in epidermal cells as expected.")
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP1-87491] - Staining of human fallopian tube shows moderate to strong positivity in plasma.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP1-87491-img0007.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP1-87491] - Staining of human kidney shows moderate to strong extracellular space positivity in cells in tubules.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP1-87491-img0008.jpg)
![Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP1-87491] - Staining of human skin shows no cytoplasmic positivity in epidermal cells as expected.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP1-87491-img0009.jpg)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: t-Plasminogen Activator/tPA Antibody [NBP1-87491] - Staining of human placenta shows strong extracelluar space positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-Immunohistochemistry-Paraffin-NBP1-87491-img0010.jpg)
![Western Blot: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - Western blot analysis of extracts of various cell lines, using tPA/t-Plasminogen Activator/tPA Rabbit mAb (NBP3-16356) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/t-Plasminogen-Activator-tPA-Antibody-10W4L1-Western-Blot-NBP3-16356-img0002.jpg "Western Blot: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - Western blot analysis of extracts of various cell lines, using tPA/t-Plasminogen Activator/tPA Rabbit mAb (NBP3-16356) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Immunocytochemistry/Immunofluorescence: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - Human placenta using tPA/PLAT Rabbit mAb (at dilution of 1:100) (Red). DAPI was used for nuclear staining (blue). Objective: 40x. Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IF staining protocol.](http://images.novusbio.com/fullsize/nbp3-16356_rabbit-t-plasminogen-activator-tpa-mab-10w4l1-immunocytochemistry-immunofluorescence-5102023103130..jpg)
![Immunocytochemistry/Immunofluorescence: t-Plasminogen Activator/tPA Antibody (10W4L1) [NBP3-16356] - NIH/3T3 cells using tPA/PLAT Rabbit mAb (at dilution of 1:100) (Red). The cells were counterstained with alpha -Tubulin Mouse mAb (dilution 1:400) (Green). DAPI was used for nuclear staining (blue). Objective: 100x.](http://images.novusbio.com/fullsize/nbp3-16356_rabbit-t-plasminogen-activator-tpa-mab-10w4l1-immunocytochemistry-immunofluorescence-5102023103255..jpg)
![Flow Cytometry: t-Plasminogen Activator/tPA Antibody (32B1) [NBP3-26377] - Overlay Peak curve showing Hela cells stained with t-Plasminogen Activator/tPA Antibody (32B1) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26377_rabbit-t-plasminogen-activator-tpa-mab-32b1-282202414183672.jpg "Flow Cytometry: t-Plasminogen Activator/tPA Antibody (32B1) [NBP3-26377] - Overlay Peak curve showing Hela cells stained with t-Plasminogen Activator/tPA Antibody (32B1) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")